Trials / Completed
CompletedNCT03246269
Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 334 (actual)
- Sponsor
- Andreas Monsch · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
This observational cohort study in healthy volunteers establishes normative data for the German version of the Montreal Cognitive Assessment (MoCA) and investigates the possible impacts of demographics on the MoCA total score.
Detailed description
The Montreal Cognitive Assessment (MoCA) is a short tool to evaluate a multitude of cognitive domains (visuospatial / executive functioning, object naming, memory, attention, language, abstraction, orientation). The original English MoCA consistently showed very high sensitivity and specificity in distinguishing patients with mild cognitive impairment from healthy controls. Therefore it is an excellent tool for early recognition of cognitive disorders. Based on a Canadian sample, the MoCA proposes a cut-off-value of 26/30 points. However, there is increasing evidence of intercultural differences in terms of the best cut-off-score. In addition the original version only slightly corrects for possible influences of education - an adjustment for age- or gender-related effects is missing. Therefore, the aim of our study was to investigate the possible impacts of demographics on the MoCA total score and to provide normative values for a German-speaking population.
Conditions
- Cognitive Impairment
- Cognitive Decline
- Cognition Disorders
- Cognitive Symptom
- Cognitive Change
- Cognitive Deterioration
- Cognitive Abnormality
- Cognitive Impairment, Mild
- Cognition Disorders in Old Age
- Dementia
- Dementia Alzheimers
- Dementia, Alzheimer Type
- Dementia, Mild
- Dementia of Alzheimer Type
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MoCA |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2017-04-01
- Completion
- 2017-04-01
- First posted
- 2017-08-11
- Last updated
- 2018-05-31
Source: ClinicalTrials.gov record NCT03246269. Inclusion in this directory is not an endorsement.